Portman Square Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Akamai
AKAM
|
+$9.85M |
| 2 |
Middleby
MIDD
|
+$8.61M |
| 3 |
Insulet
PODD
|
+$6.62M |
| 4 |
Shift4
FOUR
|
+$2.45M |
| 5 |
BridgeBio Pharma
BBIO
|
+$1.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$34M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$33.3M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$9.44M |
| 4 |
Devon Energy
DVN
|
+$6.33M |
| 5 |
ExxonMobil
XOM
|
+$4.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 0.87% |
| 2 | Industrials | 0.62% |
| 3 | Healthcare | 0.39% |
| 4 | Energy | 0.21% |
| 5 | Consumer Discretionary | 0.2% |
Similar funds
Portman Square Capital's Q1 2024 Portfolio in Review
As of Q1 2024, Portman Square Capital held 478 positions worth $3.61B, down 17% from $4.37B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Portman Square Capital withdrew a net $1.2B in Q1 2024, closing 179 positions and reducing 109 holdings. Its most notable exit was State Street Technology Select Sector SPDR ETF, an estimated $34M position sold in full.
By sector, the portfolio is most concentrated in Technology at 0.87% of assets, up from 0.63% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Portman Square Capital opened a new position in Insulet worth $6.08M.
- Portman Square Capital's largest Q1 2024 buy was Insulet: 35,495 shares worth $6.08M.
- Portman Square Capital added most to Akamai in Q1 2024, an estimated $9.85M increase.
- Portman Square Capital's biggest Q1 2024 reduction was Devon Energy, cutting an estimated $6.33M.
- Portman Square Capital fully exited State Street Technology Select Sector SPDR ETF in Q1 2024, selling an estimated $34M.
- Portman Square Capital's ten largest holdings make up 26% of its $3.61B portfolio in Q1 2024.
- Portman Square Capital opened 51 new positions and closed 179 in Q1 2024.
- Portman Square Capital's portfolio value fell 17% quarter-over-quarter to $3.61B.
Based on Portman Square Capital's 13F filing for Q1 2024, filed 15 Apr 2024.